Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
about
Clinical and molecular genetics of psychotic depressionFrom pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentPharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responseAssociation study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant responsePharmacogenetics of antidepressant response.Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.Pharmacogenetics of antidepressantsThe promise and reality of pharmacogenetics in psychiatryPredictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.Pharmacogenetics and bipolar disorder.The pharmacogenomics of selective serotonin reuptake inhibitors.Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and response.Pharmacogenomics and antidepressant drugs.A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population.Candidate genes for antidepressant response to selective serotonin reuptake inhibitorsPharmacogenomics with antidepressants in the STAR*D study.Pharmacogenetics of antidepressant response: an updatePharmacogenetics of antidepressant drugs: current clinical practice and future directions.Pharmacogenomics of bipolar disorder.Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.Investigation of serotonin-related genes in antidepressant response.Gene-environment interaction analysis of serotonin system markers with adolescent depression.The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.Prediction and structural equation model of sertraline treatment response in Japanese patients with major depressive disorder.TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression.Catecholamine pathway polymorphisms and antidepressant response.Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder.
P2860
Q27004154-073A46B3-6B61-46B0-9CC6-6B283D0D2A6BQ27015830-547AE0C7-0024-47E8-B716-EBD8A39EF530Q28252209-D8C03789-458D-4386-9C2D-B1C4DB5BF2CFQ28256653-1E55944E-2869-4577-B4DF-1B5C696C33A4Q34155796-6EA1A896-6840-4386-B962-62EA72F8FFB2Q34348095-0807196D-6868-420C-BE61-A37F6417513EQ34424865-E57992AD-900C-4BF5-8CF6-CBAF92FECB0DQ34473840-759ACD63-A7CE-4910-A878-CB560201C25BQ34871885-4E762FF3-3DF5-4CE4-BD70-80228D7C7355Q35026088-C94E0512-8596-4CC6-9094-D9DCA6BE6372Q35226451-7355625B-A2D8-42F5-AF03-49BD5F439897Q35237042-27E7731C-97F1-4AB0-AB9B-6C3653CE5FD1Q35744024-F54F11B4-A153-46F5-8077-F1E1C4FCCA37Q35757723-D845C62B-EC3C-4691-8276-151918F6B8DFQ35814369-C9AC0C1F-DC8F-4A45-AB14-93F565B0E024Q36438205-C6605A3E-EC3F-4298-AA46-CE9117BF21FFQ36677271-FAD8B837-C41C-44DE-B0D1-4D29071E19E9Q36718053-AF354456-477B-48DB-82F4-C37CE7766C8FQ37205961-AF05153B-272E-49FC-ABA0-E643CEAAFC55Q37464458-26ADA3C9-AF6B-4003-99CA-5823B55AFFADQ37989490-BFD64D42-1D8E-4735-86B8-839FE777A10FQ38097534-27DBA59E-375C-411F-BCE6-981F91438EE2Q38121519-89A2D3E1-83D6-4BCB-8153-3D9C819394F6Q38983579-63762D2C-5FDA-409F-8D55-B7410F42752DQ44820568-537F3D64-620B-4692-8577-AE20533EF69BQ44969252-4525D56E-C072-4C20-8662-7E88E008A501Q45134478-D1B5BA85-4AF1-4176-A24D-0B2A1897087DQ45280761-B9DA6AE3-8AB4-442C-AF24-4C4E89D4A577Q46171967-4E308917-74E7-499B-9286-88B6C21D264CQ46434375-AAB256D7-FE7D-4C14-974C-427CB69076EFQ48086113-DBE90353-A23C-4150-A12F-3B80CBFB04A3Q51899390-5374A1D0-7CA5-468B-AAA0-812FABFB6917
P2860
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
@en
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
@nl
type
label
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
@en
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
@nl
prefLabel
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
@en
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
@nl
P2093
P1476
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity
@en
P2093
P304
P356
10.1016/S0924-977X(01)00113-4
P407
P577
2001-10-01T00:00:00Z